622381-66-2

Basic information

• Product Name: [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL
• Synonyms: [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL;3-[(4-Methylpiperazin-1-yl)methyl]benzyl alcohol;3-[(4-Methylpiperazin-1-yl)methyl]benzyl alcohol 97%
• CAS NO: 622381-66-2
• Molecular Formula: C₁₃H₂₀N₂O
• Molecular Weight: 220.31
• Mol File: 622381-66-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 346.1°C at 760 mmHg
• Flash Point: 164.2°C
• Appearance: /
• Density: 1.097g/cm³
• Vapor Pressure: 2.22E-05mmHg at 25°C
• Refractive Index: 1.57
• CAS DataBase Reference: [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL(622381-66-2)
• EPA Substance Registry System: [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL(622381-66-2)

Safety Data

• Hazard Codes: C,Xi
• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 622381-66-2(Hazardous Substances Data)

Usage

General Description

"[3-[(4-Methylpiperazin-1-yl)methyl]phenyl]methanol" is a chemical compound with a molecular formula C17H24N2O. It is a member of the organic compound class and is characterized by the presence of a phenyl group, a methanol group, and a methylpiperazine group. [3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHANOL is used in medicinal chemistry and is often studied for its potential pharmaceutical properties. Its specific uses and applications may vary depending on the context and the specific goals of the research.

InChI:InChI=1/C13H20N2O/c1-14-5-7-15(8-6-14)10-12-3-2-4-13(9-12)11-16/h2-4,9,16H,5-8,10-11H2,1H3

Upstream product

• 109-01-3 1-methyl-piperazine 
• 1129-28-8 3-methoxycarbonylbenzyl bromide 
• 52178-50-4 Methyl 3-formylbenzoate 
• 658689-29-3 methyl 3-[(4-methyl piperazine-1-yl)-methyl]benzoate 

Downstream Products

• 859850-88-7 3-[(4-methylpiperazin-1-yl)methyl]benzaldehyde 

Relevant articles and documents

NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS

The present invention relates to novel dihydropyridine derivatives of formula (I): as modulators of nuclear receptors selected from androgen receptor and glucocorticoid receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by modulation of androgen receptor and/or glucocorticoid receptor, selected from cancer, metastasizing cancers, benign prostate hyperplasia, polycystic ovary syndrome (PCOS), hair loss, hirsutism, acne, hypogonadism, muscle wasting diseases, cachexia, Cushing's syndrome, anti-psychotic drug induced weight gain, obesity, post-traumatic stress disorder and alcoholism.

Benzothiazole Formulations and Use Thereof

The present invention is related to macrogol glyceride pharmaceutical formulations containing benzothiazole derivatives. In particular, the invention is related to benzothiazole stearoyl macrogol pharmaceutical formulations, method of preparation and use thereof.